With the uncertain economic environment, many organizations are challenged by having to align shrinking budgets with their training and development needs. While professional development remains an essential part of organizational health, it can be costly, too.

March 23, 2009 – The FDA has cleared the Nellcor OxiMax N-600x pulse oximeter with OxiMax SPD alert for adults, which enables the pulse oximeter to detect and alert clinicians of oxygen desaturation patterns, allowing them to make timely and more informed decisions about patient care.

March 23, 2009 - Pathway Medical Technologies Inc. today said the FDA granted the company 510(k) clearance to market the Jetstream G2 specifically for use in breaking apart and removing thrombus (or blood clots) from the upper and lower extremity peripheral arteries.

March 23, 2009 - FiatLux Imaging and Panasonic Computer Solutions Co. will demonstrate at HIMSS 2009 the advanced visualization capabilities of FiatLux Visualize optimized for the next generation of tablet computers for the healthcare industry including the new the Panasonic Toughbook H1 Mobile Clinical Assistant (MCA).


During TCT 2009 this past fall in Washington D.C. I had the chance to listen to Shigeru Saito, M.D., FACC, ShonanKamakura General Hospital, Sapporo, Japan, explain reasons why he feels transradial artery access for interventional procedures is better than the U.S. standard of femoral access. Dr.

March 20, 2009 - Stanford University School of Medicine researchers have pooled three years of individual patient data to compare the effectiveness of coronary artery bypass surgery versus angioplasty on specific groups of patients.

March 20, 2009 - Stanford University School of Medicine researchers have pooled three years of individual patient data to compare the effectiveness of coronary artery bypass surgery versus angioplasty on specific groups of patients.

March 20, 2009 - Endologix Inc. yesterday announced the first presentation of initial outcomes with up to two-year patient follow-up from its Powerlink Suprarenal Proximal Extension trial; the Powerlink System is for the minimally invasive treatment of abdominal aortic aneurysms (AAA).

March 19, 2009 – The enrollment phase of the RAFT clinical trial (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial) is complete, announced Medtronic Inc.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now